Optical Genome Mapping May Improve Risk Stratification in Myelofibrosis
Optical Genome Mapping improves genetic risk assessment in myelofibrosis, enabling personalized treatment decisions, earlier intervention, better monitoring, and more efficient healthcare resource use for high-risk patients.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.